1. Home
  2. CFFN vs IOVA Comparison

CFFN vs IOVA Comparison

Compare CFFN & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFFN
  • IOVA
  • Stock Information
  • Founded
  • CFFN 1893
  • IOVA 2007
  • Country
  • CFFN United States
  • IOVA United States
  • Employees
  • CFFN N/A
  • IOVA N/A
  • Industry
  • CFFN Savings Institutions
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CFFN Finance
  • IOVA Health Care
  • Exchange
  • CFFN Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • CFFN 832.5M
  • IOVA 975.1M
  • IPO Year
  • CFFN 1999
  • IOVA N/A
  • Fundamental
  • Price
  • CFFN $6.28
  • IOVA $2.34
  • Analyst Decision
  • CFFN Hold
  • IOVA Buy
  • Analyst Count
  • CFFN 1
  • IOVA 11
  • Target Price
  • CFFN $6.50
  • IOVA $11.90
  • AVG Volume (30 Days)
  • CFFN 678.0K
  • IOVA 9.6M
  • Earning Date
  • CFFN 10-29-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • CFFN 5.41%
  • IOVA N/A
  • EPS Growth
  • CFFN N/A
  • IOVA N/A
  • EPS
  • CFFN 0.47
  • IOVA N/A
  • Revenue
  • CFFN $192,483,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • CFFN $10.56
  • IOVA $68.14
  • Revenue Next Year
  • CFFN $11.73
  • IOVA $56.64
  • P/E Ratio
  • CFFN $13.36
  • IOVA N/A
  • Revenue Growth
  • CFFN N/A
  • IOVA 636.99
  • 52 Week Low
  • CFFN $4.90
  • IOVA $1.64
  • 52 Week High
  • CFFN $7.20
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • CFFN 45.92
  • IOVA 54.12
  • Support Level
  • CFFN $6.21
  • IOVA $1.97
  • Resistance Level
  • CFFN $6.46
  • IOVA $2.17
  • Average True Range (ATR)
  • CFFN 0.12
  • IOVA 0.13
  • MACD
  • CFFN -0.03
  • IOVA 0.02
  • Stochastic Oscillator
  • CFFN 21.21
  • IOVA 90.24

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: